![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif)
bispecific antibody 2B1 A monoclonal antibody with potential antineoplastic activity. Specific for both the immunoglobulin G (IgG) receptor CD16 and c-erbB-2, bispecific antibody 2B1 may enhance cellular immune responses against c-erbB-2-positive cells, resulting in increased tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif) | 2B1 2B1 antibody, bispecific 2B1 Bispecific MAb 2B1 Bispecific Murine MAb MoAb 2B1 Bispecific | | ![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif) | BsAb 2B1 | | ![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20090509165527im_/http://www.cancer.gov/images/spacer.gif) |